Cite
[18F] AlF‑NOTA‑FAPI‑04 PET/CT as a promising tool for imaging fibroblast activation protein in gastrointestinal system cancers: a prospective investigation of comparative analysis with 18F-FDG.
MLA
Yang, Liping, et al. “[18F] AlF‑NOTA‑FAPI‑04 PET/CT as a Promising Tool for Imaging Fibroblast Activation Protein in Gastrointestinal System Cancers: A Prospective Investigation of Comparative Analysis with 18F-FDG.” European Journal of Nuclear Medicine & Molecular Imaging, vol. 50, no. 13, Nov. 2023, pp. 4051–63. EBSCOhost, https://doi.org/10.1007/s00259-023-06351-9.
APA
Yang, L., Xu, S., Cheng, L., Gao, C., Cao, S., Chang, Z., & Wang, K. (2023). [18F] AlF‑NOTA‑FAPI‑04 PET/CT as a promising tool for imaging fibroblast activation protein in gastrointestinal system cancers: a prospective investigation of comparative analysis with 18F-FDG. European Journal of Nuclear Medicine & Molecular Imaging, 50(13), 4051–4063. https://doi.org/10.1007/s00259-023-06351-9
Chicago
Yang, Liping, Shichuan Xu, Liang Cheng, Chao Gao, Shaodong Cao, Zhengsong Chang, and Kezheng Wang. 2023. “[18F] AlF‑NOTA‑FAPI‑04 PET/CT as a Promising Tool for Imaging Fibroblast Activation Protein in Gastrointestinal System Cancers: A Prospective Investigation of Comparative Analysis with 18F-FDG.” European Journal of Nuclear Medicine & Molecular Imaging 50 (13): 4051–63. doi:10.1007/s00259-023-06351-9.